-- Topaz Energy (TPZ.TO) 週二盤後發布財報稱,其第一季營收和調整後利潤同比增長略有增長,並批准了季度股息增長。 這家石油和天然氣特許權使用費及基礎設施公司公佈,第一季調整後利潤(不計大部分一次性項目)為 3,820 萬美元,合每股 0.25 美元,高於去年同期的 3,800 萬美元(合每股 0.25 美元)。 FactSet 此前預期每股收益為 0.32 美元。 營收從去年同期的 9,220 萬美元增至 9,460 萬美元。 FactSet 先前預期為 9,300 萬美元。 該公司表示:“Topaz 重申先前公佈的年度平均特許權使用費產量、加工收入和其他收入範圍,但預計年度平均特許權使用費產量將處於該範圍的上限,這主要得益於強勁的石油業務活動,同時公司也保持了審慎的天然氣業務資本紀律。” 該公司補充道,預計其2026年退出時的淨債務為4.07億美元(不包括任何新的收購),併計劃將派息率維持在60%至90%目標區間的低端。 董事會將季度股息從每股0.34美元提高至每股0.35美元。股利將於6月30日支付給截至6月15日登記在冊的股東。
Related Articles
Simcere Pharmaceutical Receives Chinese Regulatory Approval to Begin Trials of Tumor Drug
Simcere Pharmaceutical (HKG:2096) received Chinese regulatory approval to begin clinical trials of SIM0613, according to a Hong Kong bourse filing Wednesday.The injection is intended to treat advanced solid tumors and is licensed to Ipsen Pharma in regions outside Greater China.
Meitu Records 30% Rise in Paying Subscribers
Meitu (HKG:1357) said the number of paying subscribers using its platform grew 30% year on year to 17.90 million as of end March, according to a Hong Kong bourse filing Wednesday.Paying subscribers for the company's productivity tools grew 53% to 2.34 million, while leisure app subscribers increased 27% to 15.56 million, the firm said.The company's core revenue grew 34.3% year on year to 852 million yuan, while other businesses remained "stable overall."The company's annual recurring revenue for AI-driven productivity apps stood at 580 million yuan as of March, a 56% increase from a year earlier.
Yidu Tech Unit Wins SG$2.3 Million Singapore Healthcare Project
Yidu Tech (HKG:2158) said its subsidiary EVYD Research Private Limited won a contract from Singapore Health Services for the implementation and support of Dr Buddy, according to a Wednesday Hong Kong bourse filing.The total project amount is about SG$2.3 million.